{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Homology modeling", "Ligand molecules", "Molecular docking", "PPAR\u03b3", "Type II diabetes"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28575810", "DateCompleted": {"Year": "2018", "Month": "04", "Day": "03"}, "DateRevised": {"Year": "2018", "Month": "04", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "05", "Day": "30"}], "Language": ["eng"], "ELocationID": ["10.1016/j.biopha.2017.05.077", "S0753-3322(16)32620-8"], "Journal": {"ISSN": "1950-6007", "JournalIssue": {"Volume": "92", "PubDate": {"Year": "2017", "Month": "Aug"}}, "Title": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie", "ISOAbbreviation": "Biomed Pharmacother"}, "ArticleTitle": "Homology modeling and molecular docking studies on Type II diabetes complications reduced PPAR\u03b3 receptor with various ligand molecules.", "Pagination": {"StartPage": "528", "EndPage": "535", "MedlinePgn": "528-535"}, "Abstract": {"AbstractText": ["Peroxisome proliferator-activated receptor gamma (PPAR\u03b3), a type II nuclear receptor present in adipose tissue, colon and macrophages. It reduces the hyperglycemia associated metabolic syndromes. Particularly, type II diabetes-related cardiovascular system risk in human beings. The fatty acid storage and glucose metabolism are regulated by PPAR\u03b3 activation in human body. According to recent reports commercially available PPAR\u03b3 activating drugs have been causing severe side effects. At the same time, natural products have been proved to be a promising area of drug discovery. Recently, many studies have been attempted to screen and identify a potential drug candidate to activate PPAR\u03b3. Hence, in this study we have selected some of the bio-active molecules from traditional medicinal plants. Molecular docking studies have been carried out against the target, PPAR\u03b3. We Results suggested that Punigluconin has a efficient docking score and it is found to have good binding affinities than other ligands. Hence, we concluded that Punigluconin is a better drug candidate for activation of PPAR\u03b3 gene expression. Further studies are necessary to confirm their efficacy and possibly it can develop as a potential drug in future."], "CopyrightInformation": "Copyright \u00a9 2017 Elsevier Masson SAS. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Phytochemistry Lab, PG and Research Department of Botany and Microbiology, AVVM Sri Pushpam College (Autonomous) Poondi, Thanjavur (Dist), Tamil Nadu, India."}], "LastName": "Prabhu", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Phytochemistry Lab, PG and Research Department of Botany and Microbiology, AVVM Sri Pushpam College (Autonomous) Poondi, Thanjavur (Dist), Tamil Nadu, India. Electronic address: svijaya_kumar2579@rediff.com."}], "LastName": "Vijayakumar", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Phytochemistry Lab, PG and Research Department of Botany and Microbiology, AVVM Sri Pushpam College (Autonomous) Poondi, Thanjavur (Dist), Tamil Nadu, India."}], "LastName": "Manogar", "ForeName": "P", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Industrial Sciences and Technology, Universiti Malaysia Pahang, Lebuhraya Tun Razak, 26300 Gambang, Kuantan, Pahang, Malaysia; Central Laboratory Universiti Malaysia Pahang, Lebuhraya Tun Razak, 26300 Gambang, Kuantan, Pahang, Malaysia."}], "LastName": "Maniam", "ForeName": "Gaanty Pragas", "Initials": "GP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Industrial Sciences and Technology, Universiti Malaysia Pahang, Lebuhraya Tun Razak, 26300 Gambang, Kuantan, Pahang, Malaysia."}], "LastName": "Govindan", "ForeName": "Natanamurugaraj", "Initials": "N"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "France", "MedlineTA": "Biomed Pharmacother", "NlmUniqueID": "8213295", "ISSNLinking": "0753-3322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Ligands"}, {"RegistryNumber": "0", "NameOfSubstance": "PPAR gamma"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Amino Acid Sequence"}, {"QualifierName": ["physiology"], "DescriptorName": "Binding Sites"}, {"QualifierName": [], "DescriptorName": "Crystallography, X-Ray"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Ligands"}, {"QualifierName": ["methods"], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["antagonists & inhibitors", "chemistry", "metabolism"], "DescriptorName": "PPAR gamma"}, {"QualifierName": ["chemistry", "metabolism", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Protein Structure, Secondary"}, {"QualifierName": [], "DescriptorName": "Protein Structure, Tertiary"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2016", "Month": "12", "Day": "6"}, {"Year": "2017", "Month": "5", "Day": "13"}, {"Year": "2017", "Month": "5", "Day": "17"}, {"Year": "2017", "Month": "6", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "3", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28575810", "10.1016/j.biopha.2017.05.077", "S0753-3322(16)32620-8"]}}]}